학술논문

Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris (R)) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
Document Type
Journal
Source
HEALTH TECHNOLOGY ASSESSMENT; MAR 2005, 9 11, p1-p+, 117p.
Subject
Language
English
ISSN
13665278